These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37415455)

  • 1. Computational approaches for molecular characterization and structure-based functional elucidation of a hypothetical protein from Mycobacterium tuberculosis.
    Saikat ASM
    Genomics Inform; 2023 Jun; 21(2):e25. PubMed ID: 37415455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of a hypothetical protein in the RD7 region in clinical isolates of Mycobacterium tuberculosis - an in silico approach to candidate vaccines.
    Kootery KP; Sarojini S
    J Genet Eng Biotechnol; 2022 Apr; 20(1):55. PubMed ID: 35394551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure analysis of the extracellular domain reveals disulfide bond forming-protein properties of Mycobacterium tuberculosis Rv2969c.
    Wang L; Li J; Wang X; Liu W; Zhang XC; Li X; Rao Z
    Protein Cell; 2013 Aug; 4(8):628-40. PubMed ID: 23828196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function prediction of Rv0079, a hypothetical Mycobacterium tuberculosis DosR regulon protein.
    Mishra S
    J Biomol Struct Dyn; 2009 Dec; 27(3):283-92. PubMed ID: 19795912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
    Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
    Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
    Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
    Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
    Logesh R; Lavanya V; Jamal S; Ahmed N
    Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of Mycobacterium tuberculosis-Specific and Nonspecific Immune Responses in Women with Tuberculosis Infection during Pregnancy.
    Tesfaye F; Sturegård E; Walles J; Bekele B; Bobosha K; Björkman P; Jansson M
    Microbiol Spectr; 2022 Oct; 10(5):e0117822. PubMed ID: 35969076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of New
    Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734
    [No Abstract]   [Full Text] [Related]  

  • 13. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17.
    Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ
    Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
    Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
    Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-positive DsbE proteins function differently from Gram-negative DsbE homologs. A structure to function analysis of DsbE from Mycobacterium tuberculosis.
    Goulding CW; Apostol MI; Gleiter S; Parseghian A; Bardwell J; Gennaro M; Eisenberg D
    J Biol Chem; 2004 Jan; 279(5):3516-24. PubMed ID: 14597624
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Olive AJ; Smith CM; Baer CE; Coers J; Sassetti CM
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction of epitopes of Rv1410c Mycobacterium tuberculosis protein using DNAStar software].
    Li J; Bai X; Liang Y; Zhang J; Yang Y; Zhao W; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):474-7. PubMed ID: 25854566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against
    Ghaffari AD; Dalimi A; Ghaffarifar F; Pirestani M; Majidiani H
    Clin Exp Vaccine Res; 2021 Jan; 10(1):59-77. PubMed ID: 33628756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.